Opportunity Information: Apply for PAR 18 639

The NIH funding opportunity PAR-18-639, titled "Innovative Approaches to Studying Cancer Communication in the New Media Environment (R21 - Clinical Trial Optional)," supports early-stage, exploratory research that brings modern, technology-forward methods into the study of how people communicate about cancer and how that communication influences prevention and care. The main idea is to encourage researchers to test fresh concepts, build or adapt new tools, and pilot novel methodological approaches that can improve cancer communication research across the entire cancer control continuum. That continuum is broad by design: projects can focus on cancer prevention, early detection and screening, diagnosis, treatment decision making, survivorship, caregiving, and even end-of-life communication.

This FOA is centered on the reality that cancer information now spreads through digital and data-rich environments, and the NIH is looking for studies that can make sense of those environments in more rigorous and innovative ways. Applicants are encouraged to use one or more cutting-edge analytic approaches, research methods, or emerging data sources. Examples explicitly highlighted include social media data mining, Natural Language Processing (NLP) for analyzing large-scale text and conversations, online social network analysis to understand how information and influence move through communities, and crowdsourcing tools such as Amazon Mechanical Turk (mTurk) for rapid testing of messages or hypotheses. The announcement also points to online search data as a way to capture real-world information seeking, Ecological Momentary Assessment to measure communication exposures and reactions in real time, neuroscience and biobehavioral approaches to understand mechanisms of message processing and persuasion, and geographic information systems (GIS) to study how communication and outcomes vary by place, community context, or resource availability. The emphasis is not on using every method, but on selecting methods that offer a clear advantage for answering an important cancer communication question in a new media context.

In terms of what the research should measure, the FOA is focused on outcomes that matter for cancer prevention and control. That includes classic communication targets like knowledge, attitudes, and beliefs, but also more applied and behavior-linked outcomes such as perceived cancer risk, screening and treatment decision making, and shared decision making between patients and clinicians. It also encourages work on information inequalities, recognizing that digital communication can reduce or widen disparities depending on who has access, trust, and the skills to evaluate information quality. Other outcomes mentioned include social support and caregiving dynamics (often mediated through online groups and platforms), persuasion and message effects, behavioral intentions, actual preventive behaviors, and policy support. In practice, this could cover topics like how misinformation spreads in cancer spaces online, how tailored messages affect screening uptake, how online communities shape survivorship coping, or how search trends relate to real-world prevention behavior, as long as the study is grounded in cancer communication and uses innovative methods suited to modern media.

The funding mechanism is the NIH Exploratory/Developmental Grant (R21), which is meant for high-potential ideas at an earlier stage of development. R21 projects are typically pilots or proof-of-concept studies where the goal is to generate insights, feasibility evidence, or initial data that can lead to larger studies later. A key point in the announcement is that an R21 application does not need extensive preliminary data or a long history of prior results. That makes this opportunity especially relevant for teams proposing new data streams (like social media APIs or search data), new analytic pipelines (like NLP classifiers), or new measurement strategies (like momentary assessments tied to digital exposures). The FOA is "clinical trial optional," meaning a proposed study may include a clinical trial if appropriate, but a clinical trial is not required.

On eligibility, the FOA is broadly open to many organization types, including state, county, city, and special district governments; public and private institutions of higher education; independent school districts; federally recognized Native American tribal governments; tribal organizations that are not federally recognized; public housing authorities and Indian housing authorities; nonprofit organizations with or without 501(c)(3) status; for-profit organizations (other than small businesses) as well as small businesses; and other eligible entities. It also explicitly highlights additional eligible applicant categories such as Historically Black Colleges and Universities (HBCUs), Hispanic-serving institutions, Tribally Controlled Colleges and Universities (TCCUs), Alaska Native and Native Hawaiian serving institutions, and Asian American Native American Pacific Islander Serving Institutions (AANAPISIs), along with faith-based or community-based organizations and certain regional organizations. While the FOA mentions "Non-domestic (non-U.S.) Entities (Foreign Organizations)," the eligibility restrictions clarified in the text state that non-domestic (non-U.S.) entities are not eligible to apply, non-domestic components of U.S. organizations are not eligible, and foreign components (as defined by NIH policy) are not allowed. In other words, applicants should plan for the work to be led and conducted within eligible U.S.-based organizational structures without foreign components.

Key administrative details provided include that this is a discretionary grant opportunity from the National Institutes of Health under CFDA 93.395, categorized under education and health. The listing shows an award ceiling of $200,000, and the original closing date noted in the source data is June 13, 2019, with a creation date of February 7, 2018. Even if dates have passed for that particular cycle, the substance of the FOA reflects NIH priorities in modernizing cancer communication research, especially research that can keep pace with rapidly changing media platforms, evolving online behaviors, and the growing availability of large-scale digital trace data.

Overall, this FOA is best understood as an invitation to bring sophisticated, newer-generation methods to real problems in cancer communication, with a strong preference for approaches that can capture the complexity of the new media environment. Competitive applications would typically make a clear case that the chosen method (for example, NLP, social network analysis, or EMA) is essential to answering the research question, that the outcomes are meaningful to cancer prevention or control, and that the project is feasible as an exploratory R21 with the potential to lead to scalable, higher-impact work later.

  • The National Institutes of Health in the education, health sector is offering a public funding opportunity titled "Innovative Approaches to Studying Cancer Communication in the New Media Environment (R21 - Clinical Trial Optional)" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.395.
  • This funding opportunity was created on 2018-02-07.
  • Applicants must submit their applications by 2019-06-13. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
  • Each selected applicant is eligible to receive up to $200,000.00 in funding.
  • Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
Apply for PAR 18 639

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Education, Health

Next opportunity: NIDCR Behavioral and Social Intervention Clinical Trial Planning and Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required)

Previous opportunity: Pragmatic Trials for Dementia Care in Long-term Services and Support (LTSS) Settings (R61/R33 - Clinical Trial Required)

Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for PAR 18 639

 

Applicants also applied for:

Applicants who have applied for this opportunity (PAR 18 639) also looked into and applied for these:

Funding Opportunity
Research Infrastructure Development for Interdisciplinary Aging Studies (R21/R33 - Clinical Trial Optional) Apply for PAR 18 645

Funding Number: PAR 18 645
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Advanced-Stage Development and Utilization of Research Infrastructure for Interdisciplinary Aging Studies (R33 - Clinical Trial Optional) Apply for PAR 18 644

Funding Number: PAR 18 644
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $500,000
SBIR Phase IIB Bridge Awards to Accelerate the Development of Cancer-Focused Technologies Toward Commercialization (R44 Clinical Trial Optional) Apply for RFA CA 18 011

Funding Number: RFA CA 18 011
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Developmentally Tailored HIV Prevention and Care Research for Adolescents and Young Adults (R01 Clinical Trial Optional) Apply for PA 18 651

Funding Number: PA 18 651
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Developmentally Tailored HIV Prevention and Care Research for Adolescents and Young Adults (R21 Clinical Trial Not Allowed) Apply for PA 18 652

Funding Number: PA 18 652
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $200,000
Basic Research in Cancer Health Disparities (R21 Clinical Trial Not Allowed) Apply for PAR 18 655

Funding Number: PAR 18 655
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $200,000
Basic Research in Cancer Health Disparities (R01 Clinical Trials Not Allowed) Apply for PAR 18 654

Funding Number: PAR 18 654
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Exploiting Omics Assays to Investigate Molecular Regulation of Persistent HIV in Individuals with Substance Use Disorder (R61/R33 Clinical Trial Optional) Apply for RFA DA 19 003

Funding Number: RFA DA 19 003
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $450,000
U.S. Tobacco Control Policies to Reduce Health Disparities (R01 Clinical Trial Optional) Apply for PAR 18 675

Funding Number: PAR 18 675
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
U.S. Tobacco Control Policies to Reduce Health Disparities (R21 Clinical Trial Optional) Apply for PAR 18 674

Funding Number: PAR 18 674
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $200,000
Epidemiologic Research on Emerging Risk Factors and Liver Cancer Susceptibility (R21 - Clinical Trial Not Allowed) Apply for PA 18 678

Funding Number: PA 18 678
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $200,000
Epidemiologic Research on Emerging Risk Factors and Liver Cancer Susceptibility (R01 - Clinical Trial Not Allowed) Apply for PA 18 677

Funding Number: PA 18 677
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Fundamental Mechanisms of Affective and Decisional Processes in Cancer Control (R01 Clinical Trial Optional) Apply for PAR 18 681

Funding Number: PAR 18 681
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Short-term Mentored Career Enhancement Awards for Mid-Career Investigators to Integrate Basic Behavioral and Social Sciences (K18 Clinical Trial Required) Apply for PAR 18 692

Funding Number: PAR 18 692
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Science-Based Quality Measurement and Management Development for Opioid Use Disorder Treatment (R61/R33 Clinical Trial Required) Apply for RFA DA 19 005

Funding Number: RFA DA 19 005
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
SBIR Technology Transfer (R43/R44 Clinical Trial Not Allowed) Apply for PA 18 705

Funding Number: PA 18 705
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Research Answers to National Cancer Institute's (NCI) Provocative Questions (R01 Clinical Trial Optional) Apply for RFA CA 18 019

Funding Number: RFA CA 18 019
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Research Answers to National Cancer Institute's (NCI) Provocative Questions (R21 Clinical Trial Optional) Apply for RFA CA 18 020

Funding Number: RFA CA 18 020
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $200,000
Advancing Exceptional Research on HIV/AIDS and Substance Abuse (R01, Clinical Trial Optional) Apply for RFA DA 18 022

Funding Number: RFA DA 18 022
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Coordinating Center to Support NIDA Rural Opioid HIV and Comorbidity Initiative (U24 - Clinical Trial Not Allowed) Apply for RFA DA 19 004

Funding Number: RFA DA 19 004
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $500,000

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

Inside Our Applicants Portal

  • Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
  • Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
  • Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Access Applicants Portal

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Learn More

 

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "PAR 18 639", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.

 

Ask a Question: